TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 242 filers reported holding TG THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,994 | -68.6% | 24,760 | -6.7% | 0.00% | -66.7% |
| Q2 2023 | $659,303 | +69.2% | 26,542 | +2.4% | 0.00% | +50.0% |
| Q1 2023 | $389,732 | +42.9% | 25,913 | +12.4% | 0.00% | +100.0% |
| Q4 2022 | $272,788 | +102.1% | 23,059 | +0.8% | 0.00% | 0.0% |
| Q3 2022 | $135,000 | +13400.0% | 22,865 | +8528.3% | 0.00% | – |
| Q2 2022 | $1,000 | -75.0% | 265 | -35.7% | 0.00% | – |
| Q1 2022 | $4,000 | +100.0% | 412 | +312.0% | 0.00% | – |
| Q4 2021 | $2,000 | -50.0% | 100 | -9.9% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 111 | -6.7% | 0.00% | – |
| Q2 2021 | $5,000 | -16.7% | 119 | -4.8% | 0.00% | – |
| Q1 2021 | $6,000 | -87.0% | 125 | -85.9% | 0.00% | -100.0% |
| Q4 2020 | $46,000 | +84.0% | 885 | -5.3% | 0.00% | – |
| Q3 2020 | $25,000 | +66.7% | 935 | +27.2% | 0.00% | – |
| Q2 2020 | $15,000 | +400.0% | 735 | +22.5% | 0.00% | – |
| Q3 2019 | $3,000 | -40.0% | 600 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q1 2019 | $5,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |